24 related articles for article (PubMed ID: 8359345)
1. HLA class II associations in juvenile Graves' disease: indication of a strong protective role of the DRB1*0701,DQA1*0201 haplotype.
Lavard L; Madsen HO; Perrild H; Jacobsen BB; Svejgaard A
Tissue Antigens; 1997 Dec; 50(6):639-41. PubMed ID: 9458117
[TBL] [Abstract][Full Text] [Related]
2. The HLA association with Graves' disease is sex-specific in Hong Kong Chinese subjects.
Cavan DA; Penny MA; Jacobs KH; Kelly MA; Jenkins D; Mijovic C; Chow C; Cockram CS; Hawkins BR; Barnett AH
Clin Endocrinol (Oxf); 1994 Jan; 40(1):63-6. PubMed ID: 8306482
[TBL] [Abstract][Full Text] [Related]
3. Immunogenetics of Graves' ophthalmopathy.
Weetman AP; So AK; Warner CA; Foroni L; Fells P; Shine B
Clin Endocrinol (Oxf); 1988 Jun; 28(6):619-28. PubMed ID: 2908181
[TBL] [Abstract][Full Text] [Related]
4. HLA DQA1*0501 and DRB1*0301 antigens do not independently convey susceptibility to Graves' disease.
Philippou G; Krimitzas A; Kaltsas G; Anastasiou E; Souvatzoglou A; Alevizaki M
J Endocrinol Invest; 2001 Feb; 24(2):88-91. PubMed ID: 11263477
[TBL] [Abstract][Full Text] [Related]
5. HLA class II alleles in Japanese patients with Graves' disease: weak associations of HLA-DR and -DQ.
Katsuren E; Awata T; Matsumoto C; Yamamoto K
Endocr J; 1994 Dec; 41(6):599-603. PubMed ID: 7704083
[TBL] [Abstract][Full Text] [Related]
6. Graves' ophthalmopathy: pathogenesis and clinical implications.
Major BJ; Busuttil BE; Frauman AG
Aust N Z J Med; 1998 Feb; 28(1):39-45. PubMed ID: 9544385
[No Abstract] [Full Text] [Related]
7. Graves' hyperthyroidism and endocrine ophthalmopathy--one or two closely related diseases?
Volpé R
Dev Ophthalmol; 1993; 25():101-11. PubMed ID: 8359344
[No Abstract] [Full Text] [Related]
8. Current insights into animal models of Graves' disease and orbitopathy.
Wiesweg B; Johnson KT; Eckstein AK; Berchner-Pfannschmidt U
Horm Metab Res; 2013 Aug; 45(8):549-55. PubMed ID: 23613015
[TBL] [Abstract][Full Text] [Related]
9. Biological activity of antibodies circulating in endocrine ophthalmopathy.
Nauman JA
Dev Ophthalmol; 1993; 25():29-37. PubMed ID: 8359351
[No Abstract] [Full Text] [Related]
10. Urinary and plasma glycosaminoglycans in endocrine ophthalmopathy.
Schuler M; Hansen C; Winand R; Stover C; Otto E; Beyer J; Kahaly G
Dev Ophthalmol; 1993; 25():58-67. PubMed ID: 8359354
[No Abstract] [Full Text] [Related]
11. Immunogenetics of endocrine ophthalmopathy and Graves' disease.
Badenhoop K; Schleusener H; Usadel KH
Dev Ophthalmol; 1993; 25():11-9. PubMed ID: 8359345
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
